BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ChamberMaster//Event Calendar 2.0//EN
METHOD:PUBLISH
X-PUBLISHED-TTL:P1H
REFRESH-INTERVAL:P1H
CALSCALE:GREGORIAN
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
DTSTART:20070101T000000
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:Eastern Daylight Time
END:DAYLIGHT
BEGIN:STANDARD
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
DTSTART:20070101T000000
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:Eastern Standard Time
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260929T110000
DTEND;TZID=America/New_York:20260929T120000
X-MICROSOFT-CDO-ALLDAYEVENT:FALSE
SUMMARY:Prescription Drug Update: Navigating Trends\, Costs & What's Ahead for 2027
DESCRIPTION:Prescription drug costs remain a top concern for plan sponsors\, and the landscape keeps shifting. From rising GLP-1 utilization to biosimilar developments and IRA-driven pricing changes\, staying current is essential for smart planning. Join Conrad Siegel's Health & Welfare Team for a look at where prescription drug spend is heading. Using client examples and survey data\, this session covers year-over-year Rx and GLP-1 trends\, weight management coverage decisions\, and the cost\, rebate\, and contract implications employers should watch. \nBy the end of this session\, attendees will be able to: Identify key drivers of prescription drug trend\, including client Rx/GLP-1 spend data and survey benchmarks on weight management coverage.Understand the evolving biosimilar landscape and its impact on cost management.Explain how IRA drug pricing provisions are affecting the market.Assess how market changes affect cost\, contracts\, and cash flow\, and identify next steps ahead of 2027.Register Here: https://conradsiegel.zoom.us/webinar/register/WN_k9ptVbxZRtqwfUrOxMcfwQ
X-ALT-DESC;FMTTYPE=text/html:Prescription drug costs remain a top concern for plan sponsors\, and the landscape keeps shifting. From rising GLP-1 utilization to biosimilar developments and IRA-driven pricing changes\, staying current is essential for smart planning.
\;
Join Conrad Siegel'\;s Health &\; Welfare Team for a look at where prescription drug spend is heading. Using client examples and survey data\, this session covers year-over-year Rx and GLP-1 trends\, weight management coverage decisions\, and the cost\, rebate\, and contract implications employers should watch. \;
By the end of this session\, attendees will be able to:
\;
- Identify key drivers of prescription drug trend\, including client Rx/GLP-1 spend data and survey benchmarks on weight management coverage.
- Understand the evolving biosimilar landscape and its impact on cost management.
- Explain how IRA drug pricing provisions are affecting the market.